CN104685067A - 用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒 - Google Patents

用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒 Download PDF

Info

Publication number
CN104685067A
CN104685067A CN201380031747.7A CN201380031747A CN104685067A CN 104685067 A CN104685067 A CN 104685067A CN 201380031747 A CN201380031747 A CN 201380031747A CN 104685067 A CN104685067 A CN 104685067A
Authority
CN
China
Prior art keywords
expression
array
cell
comprise measures
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380031747.7A
Other languages
English (en)
Chinese (zh)
Inventor
M.林德斯泰特
C.伯莱拜克
H.乔汉森
A-S.阿尔布雷克特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SenzaGen AB
Original Assignee
SenzaGen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SenzaGen AB filed Critical SenzaGen AB
Publication of CN104685067A publication Critical patent/CN104685067A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/14—Disorders of ear, nose or throat
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201380031747.7A 2012-04-26 2013-04-26 用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒 Pending CN104685067A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201207297A GB201207297D0 (en) 2012-04-26 2012-04-26 Analytical methods and arrays for use in the same
GB1207297.1 2012-04-26
PCT/IB2013/053321 WO2013160882A1 (en) 2012-04-26 2013-04-26 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method.

Publications (1)

Publication Number Publication Date
CN104685067A true CN104685067A (zh) 2015-06-03

Family

ID=46261886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031747.7A Pending CN104685067A (zh) 2012-04-26 2013-04-26 用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒

Country Status (10)

Country Link
US (2) US20150111771A1 (https=)
EP (1) EP2841599A4 (https=)
KR (1) KR20150016523A (https=)
CN (1) CN104685067A (https=)
BR (1) BR112014026582A2 (https=)
CA (1) CA2871350A1 (https=)
GB (1) GB201207297D0 (https=)
HK (1) HK1211059A1 (https=)
IN (1) IN2014MN02397A (https=)
WO (1) WO2013160882A1 (https=)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108304912A (zh) * 2017-12-29 2018-07-20 北京理工大学 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法
CN109828113A (zh) * 2017-11-23 2019-05-31 复旦大学附属肿瘤医院 PAPSS1在制备筛选α干扰素治疗肝癌敏感人群标志物的制剂中的用途
CN111295441A (zh) * 2017-09-25 2020-06-16 森扎基因有限责任公司 新颖细胞系和其用途
CN111596067A (zh) * 2020-06-03 2020-08-28 四川大学华西第二医院 Zc3h8在pop早期预警、诊断、预后评估中的应用和产品
CN113260715A (zh) * 2019-01-03 2021-08-13 森扎基因有限责任公司 识别能够诱发呼吸道致敏的试剂的方法和用于该方法的阵列和分析试剂盒

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421207D0 (en) * 2014-11-28 2015-01-14 Senzagen Ab Analytical methods and arrays for use in the same
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
JP7023857B2 (ja) * 2016-03-23 2022-02-22 センソシェン アクティエ ボラーグ 解析方法およびそれに用いるアレイ
TWI793151B (zh) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
AR116109A1 (es) 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
DK3820573T3 (da) 2018-07-10 2023-10-23 Novartis Ag 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme
EP4130739A4 (en) * 2020-03-25 2023-06-14 FUJIFILM Corporation METHOD FOR MEASUREMENT OF RESPIRATORY SENSITIZATION AND REAGENT FOR MEASUREMENT OF RESPIRATORY SENSITIZATION
CA3222964A1 (en) * 2021-07-02 2023-01-05 Regeneron Pharmaceuticals, Inc. Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008037806A2 (en) * 2006-09-29 2008-04-03 Vlaamse Instelling Voor Technologisch Onderzoek (Vito) Method for determining the allergic potential of a compound
US20090039868A1 (en) * 2005-05-12 2009-02-12 Michel Montreuil Current sensor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20090029868A1 (en) * 2006-10-31 2009-01-29 Applera Corporation Expression signature in peripheral blood for detection of aortic aneurysm
GB201018014D0 (en) 2010-10-26 2010-12-08 Senzagen Ab Analytical methods and arrays for use in the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090039868A1 (en) * 2005-05-12 2009-02-12 Michel Montreuil Current sensor
WO2008037806A2 (en) * 2006-09-29 2008-04-03 Vlaamse Instelling Voor Technologisch Onderzoek (Vito) Method for determining the allergic potential of a compound

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GALVAO DOS SANTOS: "Progress on development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound", 《TOXICOLOGY AND APPLIED PHARMACOLOGY》 *
HOLDEN NJ: "Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with different cytokine production and altered stimulatory capacity", 《CLINICAL AND EXPERIMENTAL ALLERGY》 *
VERSTRAELEN S: "Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization", 《TOXICOLOGY IN VITRO》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111295441A (zh) * 2017-09-25 2020-06-16 森扎基因有限责任公司 新颖细胞系和其用途
CN111295441B (zh) * 2017-09-25 2024-03-26 森扎基因有限责任公司 新颖细胞系和其用途
CN109828113A (zh) * 2017-11-23 2019-05-31 复旦大学附属肿瘤医院 PAPSS1在制备筛选α干扰素治疗肝癌敏感人群标志物的制剂中的用途
CN108304912A (zh) * 2017-12-29 2018-07-20 北京理工大学 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法
CN108304912B (zh) * 2017-12-29 2020-12-29 北京理工大学 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法
CN113260715A (zh) * 2019-01-03 2021-08-13 森扎基因有限责任公司 识别能够诱发呼吸道致敏的试剂的方法和用于该方法的阵列和分析试剂盒
CN111596067A (zh) * 2020-06-03 2020-08-28 四川大学华西第二医院 Zc3h8在pop早期预警、诊断、预后评估中的应用和产品
CN111596067B (zh) * 2020-06-03 2021-06-22 四川大学华西第二医院 Zc3h8在pop早期预警、诊断、预后评估中的应用和产品

Also Published As

Publication number Publication date
EP2841599A1 (en) 2015-03-04
US20170283874A1 (en) 2017-10-05
IN2014MN02397A (https=) 2015-08-21
GB201207297D0 (en) 2012-06-06
BR112014026582A2 (pt) 2017-06-27
WO2013160882A1 (en) 2013-10-31
KR20150016523A (ko) 2015-02-12
CA2871350A1 (en) 2013-10-31
HK1211059A1 (en) 2016-05-13
US20150111771A1 (en) 2015-04-23
EP2841599A4 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
CN104685067A (zh) 用于鉴定能够诱导呼吸道致敏的物质的方法和用于该方法中的阵列和分析试剂盒
Kotliarov et al. Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus
ES2639406T3 (es) Procedimientos analíticos y matrices para su uso en la identificación de agentes que inducen la sensibilización en la piel humana
US10859572B2 (en) Biomarker signatures and uses thereof
TW201805430A (zh) 分析方法及用於該分析方法的陣列
US20170285010A1 (en) Analytical Methods and Arrays for Use in the Same
JP6232375B2 (ja) 化合物の感受性ポテンシャルを決定するための材料と方法
CN109690312A (zh) 生物标记特征和其用途
EP3615689B1 (en) Analytical methods and arrays for use in the same
JP7590970B2 (ja) 分析方法およびそれにおいて使用するためのアレイ
TW202129009A (zh) 分析方法及用於其中的陣列
HK40024606B (en) Analytical methods and arrays for use in the same
HK1189245B (en) Analytical methods and arrays for use in the identification of agents inducing sensitization in human skin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1211059

Country of ref document: HK

CB02 Change of applicant information

Address after: Longde, Sweden

Applicant after: Senzagen Ab

Address before: Swedish Ben Rand

Applicant before: Senzagen Ab

CB02 Change of applicant information
RJ01 Rejection of invention patent application after publication

Application publication date: 20150603

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1211059

Country of ref document: HK